Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$175,325
+$32,207 QoQ
Shares Held
7,894
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#170
of 245 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Derivatives in DYN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$790,676
PutShares
35,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. DYN ranks #68 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in DYN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,325 | 7,894 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $790,676 | 35,600 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $645,428 | 35,600 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $143,118 | 7,894 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $217,116 | 11,100 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $48,900 | 2,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $140,415 | 11,100 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,265,000 | 100,000 | Call | Sole | 2025-11-14 | |
| 2023-12-31 | $2,490,930 | 187,288 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $5,322,660 | 400,200 | Call | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||